Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome - Navarese, E P; Schulze, V; Andreotti, F (JACC Cardiovasc Interv, 2015)
(1 Pt B):